Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID DTD0227 Transporter Info
Gene Name SLC26A1
Transporter Name Sulfate anion transporter 1
Gene ID
10861
UniProt ID
Q9H2B4
Epigenetic Regulations of This DT (EGR)

Methylation

  Colon cancer

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in colon adenocarcinoma [ 1 ]

Location

 5'UTR (cg03256780)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.16E+00 Statistic Test p-value: 4.05E-03; Z-score: -9.50E-01

Methylation in Case

 3.24E-01 (Median) Methylation in Control 3.78E-01 (Median)

Studied Phenotype

 Colon cancer [ ICD-11: 2B90]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in colon adenocarcinoma [ 1 ]

Location

 Body (cg09146645)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.06E+00 Statistic Test p-value: 5.73E-04; Z-score: -1.44E+00

Methylation in Case

 6.46E-01 (Median) Methylation in Control 6.85E-01 (Median)

Studied Phenotype

 Colon cancer [ ICD-11: 2B90]

Experimental Material

 Patient tissue samples

  Hepatocellular carcinoma

            8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 5'UTR (cg04897230)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.39E+00 Statistic Test p-value: 2.55E-13; Z-score: -3.72E+00

Methylation in Case

 5.56E-01 (Median) Methylation in Control 7.74E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 Body (cg27249906)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.56E+00 Statistic Test p-value: 2.55E-15; Z-score: -1.34E+01

Methylation in Case

 6.20E-01 (Median) Methylation in Control 9.69E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.44E+00 Statistic Test p-value: 2.11E-09; Z-score: -1.50E+00

Methylation in Case

 3.72E-01 (Median) Methylation in Control 5.35E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.22E+00 Statistic Test p-value: 1.99E-04; Z-score: -9.10E-01

Methylation in Case

 2.25E-01 (Median) Methylation in Control 2.75E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.37E+00 Statistic Test p-value: 3.16E-04; Z-score: -9.64E-01

Methylation in Case

 1.71E-01 (Median) Methylation in Control 2.35E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 Body (cg25025399)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.02E+00 Statistic Test p-value: 5.85E-04; Z-score: -6.74E-01

Methylation in Case

 8.57E-01 (Median) Methylation in Control 8.73E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 7

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 3'UTR (cg15090262)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.23E+00 Statistic Test p-value: 5.64E-11; Z-score: -6.43E+00

Methylation in Case

 6.10E-01 (Median) Methylation in Control 7.52E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 8

 Methylation of SLC26A1 in hepatocellular carcinoma [ 2 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.07E+00 Statistic Test p-value: 4.87E-02; Z-score: 1.12E+00

Methylation in Case

 8.18E-01 (Median) Methylation in Control 7.67E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Pancretic ductal adenocarcinoma

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in pancretic ductal adenocarcinoma [ 3 ]

Location

 TSS1500 (cg18194306)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 3.73E+00 Statistic Test p-value: 6.07E-07; Z-score: 1.57E+00

Methylation in Case

 2.64E-01 (Median) Methylation in Control 7.06E-02 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in pancretic ductal adenocarcinoma [ 3 ]

Location

 Body (cg18705155)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.38E+00 Statistic Test p-value: 2.05E-05; Z-score: -1.43E+00

Methylation in Case

 4.24E-01 (Median) Methylation in Control 5.85E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC26A1 in pancretic ductal adenocarcinoma [ 3 ]

Location

 Body (cg05399320)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.14E+00 Statistic Test p-value: 8.74E-05; Z-score: -1.11E+00

Methylation in Case

 5.51E-01 (Median) Methylation in Control 6.31E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Prostate cancer

            4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in prostate cancer [ 4 ]

Location

 TSS1500 (cg23391214)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.47E+00 Statistic Test p-value: 2.99E-02; Z-score: -1.86E+00

Methylation in Case

 1.38E-01 (Median) Methylation in Control 2.02E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in prostate cancer [ 4 ]

Location

 TSS1500 (cg18158015)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.23E+00 Statistic Test p-value: 3.37E-02; Z-score: 1.90E+00

Methylation in Case

 8.06E-01 (Median) Methylation in Control 6.55E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC26A1 in prostate cancer [ 4 ]

Location

 Body (cg15992532)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.01E+00 Statistic Test p-value: 1.05E-02; Z-score: 2.84E+00

Methylation in Case

 9.86E-01 (Median) Methylation in Control 9.76E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC26A1 in prostate cancer [ 4 ]

Location

 Body (cg08605458)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.08E+00 Statistic Test p-value: 1.16E-02; Z-score: 2.62E+00

Methylation in Case

 9.10E-01 (Median) Methylation in Control 8.41E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Atypical teratoid rhabdoid tumor

            6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.07E+00 Statistic Test p-value: 1.08E-03; Z-score: -8.77E-01

Methylation in Case

 8.36E-01 (Median) Methylation in Control 8.98E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.28E+00 Statistic Test p-value: 8.21E-03; Z-score: -8.34E-01

Methylation in Case

 2.20E-01 (Median) Methylation in Control 2.81E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.57E+00 Statistic Test p-value: 1.03E-02; Z-score: -5.20E-01

Methylation in Case

 1.18E-01 (Median) Methylation in Control 1.85E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 Body (cg10467352)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 1.48E-02; Z-score: -2.82E-01

Methylation in Case

 7.72E-01 (Median) Methylation in Control 7.95E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.02E+00 Statistic Test p-value: 1.99E-02; Z-score: 7.81E-02

Methylation in Case

 7.91E-02 (Median) Methylation in Control 7.75E-02 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC26A1 in atypical teratoid rhabdoid tumor [ 5 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.49E+00 Statistic Test p-value: 2.31E-13; Z-score: -2.25E+00

Methylation in Case

 5.84E-01 (Median) Methylation in Control 8.68E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

 Patient tissue samples

  Bladder cancer

            7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -2.80E+00 Statistic Test p-value: 3.54E-13; Z-score: -1.46E+01

Methylation in Case

 2.71E-01 (Median) Methylation in Control 7.59E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -2.49E+00 Statistic Test p-value: 1.45E-11; Z-score: -1.13E+01

Methylation in Case

 1.81E-01 (Median) Methylation in Control 4.51E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -2.70E+00 Statistic Test p-value: 2.75E-11; Z-score: -1.09E+01

Methylation in Case

 1.56E-01 (Median) Methylation in Control 4.21E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg23958868)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -2.22E+00 Statistic Test p-value: 4.08E-08; Z-score: -6.87E+00

Methylation in Case

 1.77E-01 (Median) Methylation in Control 3.93E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 1.77E-04; Z-score: -5.07E+00

Methylation in Case

 9.27E-01 (Median) Methylation in Control 9.51E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg16868776)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.08E+00 Statistic Test p-value: 2.27E-03; Z-score: -2.43E+00

Methylation in Case

 7.63E-01 (Median) Methylation in Control 8.26E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 7

 Methylation of SLC26A1 in bladder cancer [ 6 ]

Location

 Body (cg25025399)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 4.48E-02; Z-score: -2.88E-01

Methylation in Case

 8.17E-01 (Median) Methylation in Control 8.25E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Breast cancer

            7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.39E+00 Statistic Test p-value: 6.13E-14; Z-score: -2.40E+00

Methylation in Case

 4.08E-01 (Median) Methylation in Control 5.67E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg23958868)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.34E+00 Statistic Test p-value: 1.98E-13; Z-score: -2.37E+00

Methylation in Case

 4.52E-01 (Median) Methylation in Control 6.07E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.59E+00 Statistic Test p-value: 1.08E-09; Z-score: -1.80E+00

Methylation in Case

 3.35E-01 (Median) Methylation in Control 5.34E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.16E+00 Statistic Test p-value: 2.63E-09; Z-score: -2.01E+00

Methylation in Case

 6.48E-01 (Median) Methylation in Control 7.49E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.02E+00 Statistic Test p-value: 8.91E-05; Z-score: -1.17E+00

Methylation in Case

 9.29E-01 (Median) Methylation in Control 9.50E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg16868776)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.12E+00 Statistic Test p-value: 5.75E-04; Z-score: -8.22E-01

Methylation in Case

 7.40E-01 (Median) Methylation in Control 8.30E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 7

 Methylation of SLC26A1 in breast cancer [ 7 ]

Location

 Body (cg25025399)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.04E+00 Statistic Test p-value: 1.25E-03; Z-score: -9.79E-01

Methylation in Case

 8.29E-01 (Median) Methylation in Control 8.61E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Renal cell carcinoma

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in clear cell renal cell carcinoma [ 8 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.04E+00 Statistic Test p-value: 3.48E-03; Z-score: -6.43E-01

Methylation in Case

 7.83E-01 (Median) Methylation in Control 8.18E-01 (Median)

Studied Phenotype

 Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in clear cell renal cell carcinoma [ 8 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.06E+00 Statistic Test p-value: 2.75E-02; Z-score: -6.61E-01

Methylation in Case

 3.83E-01 (Median) Methylation in Control 4.07E-01 (Median)

Studied Phenotype

 Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

 Patient tissue samples

  Colorectal cancer

            5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in colorectal cancer [ 9 ]

Location

 Body (cg25025399)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 2.25E-06; Z-score: -1.85E+00

Methylation in Case

 8.98E-01 (Median) Methylation in Control 9.21E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in colorectal cancer [ 9 ]

Location

 Body (cg18168751)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 6.62E-05; Z-score: -6.97E-01

Methylation in Case

 9.63E-01 (Median) Methylation in Control 9.68E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC26A1 in colorectal cancer [ 9 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.00E+00 Statistic Test p-value: 6.59E-04; Z-score: -7.05E-01

Methylation in Case

 9.70E-01 (Median) Methylation in Control 9.73E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC26A1 in colorectal cancer [ 9 ]

Location

 Body (cg23958868)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.18E+00 Statistic Test p-value: 1.43E-03; Z-score: -1.16E+00

Methylation in Case

 4.95E-01 (Median) Methylation in Control 5.86E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC26A1 in colorectal cancer [ 9 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.07E+00 Statistic Test p-value: 2.43E-05; Z-score: -9.14E-01

Methylation in Case

 8.31E-01 (Median) Methylation in Control 8.86E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  HIV infection

            8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.20E+00 Statistic Test p-value: 6.85E-05; Z-score: 1.53E+00

Methylation in Case

 4.28E-01 (Median) Methylation in Control 3.57E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.31E+00 Statistic Test p-value: 1.20E-04; Z-score: 1.18E+00

Methylation in Case

 3.14E-01 (Median) Methylation in Control 2.39E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg04969220)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.02E+00 Statistic Test p-value: 4.03E-03; Z-score: 5.84E-01

Methylation in Case

 8.75E-01 (Median) Methylation in Control 8.54E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg23958868)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.11E+00 Statistic Test p-value: 5.99E-03; Z-score: 5.19E-01

Methylation in Case

 4.37E-01 (Median) Methylation in Control 3.95E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg16868776)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 1.04E-02; Z-score: -5.85E-01

Methylation in Case

 8.03E-01 (Median) Methylation in Control 8.25E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg25025399)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 2.88E-02; Z-score: -6.73E-01

Methylation in Case

 9.19E-01 (Median) Methylation in Control 9.32E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 7

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 Body (cg21743826)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.07E+00 Statistic Test p-value: 4.90E-02; Z-score: -5.47E-01

Methylation in Case

 7.63E-01 (Median) Methylation in Control 8.20E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 8

 Methylation of SLC26A1 in HIV infection [ 10 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.71E+00 Statistic Test p-value: 4.72E-10; Z-score: 3.43E+00

Methylation in Case

 7.78E-01 (Median) Methylation in Control 4.54E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Lung adenocarcinoma

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in lung adenocarcinoma [ 11 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.22E+00 Statistic Test p-value: 9.70E-03; Z-score: -2.99E+00

Methylation in Case

 4.27E-01 (Median) Methylation in Control 5.20E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in lung adenocarcinoma [ 11 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 3.46E-02; Z-score: -1.78E+00

Methylation in Case

 9.50E-01 (Median) Methylation in Control 9.62E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC26A1 in lung adenocarcinoma [ 11 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.12E+00 Statistic Test p-value: 1.82E-02; Z-score: 1.42E+00

Methylation in Case

 7.63E-01 (Median) Methylation in Control 6.82E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Papillary thyroid cancer

            5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in papillary thyroid cancer [ 12 ]

Location

 Body (cg11017086)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.20E+00 Statistic Test p-value: 3.90E-03; Z-score: -1.09E+00

Methylation in Case

 2.90E-01 (Median) Methylation in Control 3.47E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC26A1 in papillary thyroid cancer [ 12 ]

Location

 Body (cg10467352)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 4.19E-03; Z-score: -4.37E-01

Methylation in Case

 9.38E-01 (Median) Methylation in Control 9.44E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC26A1 in papillary thyroid cancer [ 12 ]

Location

 Body (cg23958868)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.17E+00 Statistic Test p-value: 6.48E-03; Z-score: -9.86E-01

Methylation in Case

 3.04E-01 (Median) Methylation in Control 3.56E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC26A1 in papillary thyroid cancer [ 12 ]

Location

 Body (cg09359391)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.10E+00 Statistic Test p-value: 1.86E-02; Z-score: -6.94E-01

Methylation in Case

 3.65E-01 (Median) Methylation in Control 4.02E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC26A1 in papillary thyroid cancer [ 12 ]

Location

 Body (cg08848753)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.00E+00 Statistic Test p-value: 4.09E-02; Z-score: -4.63E-01

Methylation in Case

 9.31E-01 (Median) Methylation in Control 9.34E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Panic disorder

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC26A1 in panic disorder [ 13 ]

Location

 3'UTR (cg07658508)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -4.06E-01 Statistic Test p-value: 1.21E-03; Z-score: -4.30E-01

Methylation in Case

 -5.63E-01 (Median) Methylation in Control -2.29E-01 (Median)

Studied Phenotype

 Panic disorder [ ICD-11: 6B01]

Experimental Material

 Patient tissue samples
References
1 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
2 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
3 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
4 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
5 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
6 DNA Methylation Dynamics in Urological Tumors.
7 Genome-wide Scan for Methylation Profiles in Breast Cancer
8 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
9 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
10 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
11 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
12 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
13 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.